Felicitex Therapeutics Competitors and Similar CompaniesClear all
Felicitex Therapeutics's competitors and similar companies include CHUGAI PHARMA FRANCE, Pyxis Oncology, Kinnate Biopharma and Debiopharm.
 Felicitex Therapeutics Felicitex Therapeutics is a company developing treatments for dormant cancers. |  Pyxis Oncology Pyxis Oncology is a preclinical oncology company focused on developing therapeutics to target difficult-to-treat cancers. |  Kinnate Biopharma Kinnate Biopharma is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. |  Debiopharm Debiopharm is a biopharmaceutical company specializing in oncology and bacterial infections. | ||
Founding Date | Founding Date 2014 | Founding Date 1998 | Founding Date 2019 | Founding Date 2018 | Founding Date 1979 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Natick, US HQ | Locations Paris, FR HQ | Locations Cambridge, US HQ | Locations San Diego, US HQ | Locations Lausanne, CH HQ Oss, NL |
Employees | Employees 3 | Employees 73 | Employees 39 | Employees 2757% decrease | Employees 4771% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 227 m | Valuation ($) 125 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income ($79.6m) (FY, 2025) | Net income ($112.6m) (FY, 2023) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 174m | Total funding raised $ 172.5m | Total funding raised $ 2.1m |
For sources of this data, please see the company profile
View Company Profiles
CHUGAI PHARMA FRANCE
HQ
Paris, FR
CHUGAI PHARMA FRANCE is a company that specializes in pharmaceutical products.
View companyPyxis Oncology
HQ
Cambridge, US
Employees
39
Pyxis Oncology is a preclinical oncology company focused on developing therapeutics to target difficult-to-treat cancers.
View companyKinnate Biopharma
HQ
San Diego, US
Employees
27
Kinnate Biopharma is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers.
View companyDebiopharm
HQ
Lausanne, CH
Employees
477↓ 1% decrease
Debiopharm is a biopharmaceutical company specializing in oncology and bacterial infections.
View company